Geographically, North America accounts for the largest share in the 3D bioprinting market, mainly driven by technological advancements and increasing research and development (R&D) activities in the region.

Geographically, Europe dominated the global market of patient handling equipment in 2015; whereas the North American market is expected to witness the fastest growth, a CAGR of 11.0% during the forecast period.